Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)

Bibliographic Details
Main Author:	Yan Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Endocrinology
Subjects:	adipokine hepatokines myokines nonalcoholic fatty live disease liver
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1074842/full

Similar Items

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2022-09-01)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2023-09-01)

Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
by: Ana Rita de Oliveira dos Santos, et al.
Published: (2021-03-01)

Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation
by: Yakun Ren, et al.
Published: (2022-07-01)

FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases
by: Nobuyuki eItoh
Published: (2014-07-01)

Hepatokines and Adipokines in Metabolic Syndrome
by: Alpana Mukhuty, et al.
Published: (2023-01-01)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
by: Simona Alexandra Iacob, et al.
Published: (2022-03-01)

The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
by: Li Qin, et al.
Published: (2023-04-01)

Editorial: Integrative exercise endocrinology
by: Katarina Tomljenoviċ Borer, et al.
Published: (2024-01-01)

Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals
by: Marenao Tanaka, et al.
Published: (2022-05-01)

Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
by: Antonio García-Hermoso, et al.
Published: (2023-03-01)

Organokines, Sarcopenia, and Metabolic Repercussions: The Vicious Cycle and the Interplay with Exercise
by: Giulia Minniti, et al.
Published: (2022-11-01)

Organokines in Rheumatoid Arthritis: A Critical Review
by: Lucas Fornari Laurindo, et al.
Published: (2022-05-01)

Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
by: Pamela Senesi, et al.
Published: (2020-11-01)

The Potential Role of Myokines/Hepatokines in the Progression of Neuronal Damage in Streptozotocin and High-Fat Diet-Induced Type 2 Diabetes Mellitus Mice
by: Heaji Lee, et al.
Published: (2022-06-01)

Editorial: Myokines, Adipokines, Cytokines in Muscle Pathophysiology, Volume II
by: Valentina Di Felice, et al.
Published: (2022-05-01)

Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD
by: Sechang Oh, et al.
Published: (2021-06-01)

Pharmacological and physiological roles of adipokines and myokines in metabolic-related dementia
by: Archana Arjunan, et al.
Published: (2023-07-01)

Editorial: The liver as an endocrine organ: Hepatokines and ketone bodies, novel hormones to be acknowledged
by: Renata Risi, et al.
Published: (2023-01-01)

Maresin 1 Exerts a Tissue-Specific Regulation of Adipo-Hepato-Myokines in Diet-Induced Obese Mice and Modulates Adipokine Expression in Cultured Human Adipocytes in Basal and Inflammatory Conditions
by: Leyre Martínez-Fernández, et al.
Published: (2023-05-01)

The Role of Adipokines and Myokines in the Pathogenesis of Different Obesity Phenotypes—New Perspectives
by: Marta Pelczyńska, et al.
Published: (2023-11-01)

Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy
by: Andreas Schmid, et al.
Published: (2022-11-01)

The Role of Organokines in Obesity and Type 2 Diabetes and Their Functions as Molecular Transducers of Nutrition and Exercise
by: Ji Ye Lim, et al.
Published: (2023-08-01)

Organ Crosstalk and the Modulation of Insulin Signaling
by: Alejandra Romero, et al.
Published: (2021-08-01)

The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects
by: Zhanghao Li, et al.
Published: (2023-04-01)

Content of adipokines and myokines in the blood of children and adolescents with obesity with polymorphism of the gene of liver triacylglycerol lipase rs2070895
by: A. V. Shestopalov, et al.
Published: (2024-04-01)

Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance
by: Tomoko Uchiyama, et al.
Published: (2021-11-01)

Liver Fetuin-A at Initiation of Insulin Resistance
by: Nicolas Lanthier, et al.
Published: (2022-10-01)

Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
by: Aikaterini Giannouli, et al.
Published: (2023-09-01)

The content of adipokines and myokines in the blood of children and adolescents with different genotypes according to the polymorphism rs662 of the paraoxonase-1 gene
by: A. V. Shestopalov, et al.
Published: (2023-11-01)

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity
by: Hajnalka Lőrincz, et al.
Published: (2023-02-01)

Relationships between Body Weight Status and Serum Levels of Adipokine, Myokine and Bone Metabolism Parameters in Healthy Normal Weight and Thin Children
by: Jadwiga Ambroszkiewicz, et al.
Published: (2022-07-01)

What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
by: Giovanni Tarantino, et al.
Published: (2024-02-01)

Alterations of the Adipo–Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic Implications
by: Irene Karampela, et al.
Published: (2024-02-01)

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
by: Un Ju Jung, et al.
Published: (2014-04-01)

Editorial: Myokines, Adipokines, Cytokines in Muscle Pathophysiology
by: Valentina Di Felice, et al.
Published: (2020-10-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

The effect of Ramadan fasting on non-alcoholic fatty liver disease (NAFLD) patients
by: Seyed Mostafa Arabi, et al.
Published: (2015-06-01)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
by: Lucia Carulli, et al.
Published: (2019-02-01)

Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without Medication
by: Masato Furuhashi, et al.
Published: (2022-03-01)